Skip to main content

Table 4 Determinants of unfavorable treatment outcome at the end of follow-up among those who restarted treatment for HAART after treatment interruption (n = 3,922)

From: Patients who restart antiretroviral medication after interruption remain at high risk of unfavorable outcomes in Ethiopia

Variable Sub-category Hazard ratio, crude P- value Hazard ratio, adj P-value
Age <15 1    
≥15 1.4 0.300   
Gender Female 1   1  
Male 1.6 <0.001 1.6 <0.001
Baseline WHO Stage I or II 1   1  
III or IV 1.2 0.061 1.3 0.014
Baseline CD4 <100 1    
100–349 0.8 0.049 0.9 0.138
≥350 0.8 0.112 0.8 0.178
Time to 1st interruption <6 months 1   1  
≥ 6 months 0.4 <0.001 0.3 <0.001
Time to 1st restart < 6 months 1   1  
≥ 6 months 0.3 <0.001 0.2 <0.001